Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nexgel Inc (NXGL)

Nexgel Inc (NXGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,948
  • Shares Outstanding, K 8,143
  • Annual Sales, $ 8,690 K
  • Annual Income, $ -3,280 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.59
  • Price/Sales 1.46
  • Price/Cash Flow N/A
  • Price/Book 2.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4500 +9.66%
on 12/10/25
2.0199 -21.28%
on 12/11/25
+0.0100 (+0.63%)
since 11/24/25
3-Month
1.4500 +9.66%
on 12/10/25
2.8899 -44.98%
on 10/09/25
-0.8300 (-34.30%)
since 09/24/25
52-Week
1.4500 +9.66%
on 12/10/25
4.9500 -67.88%
on 12/26/24
-3.1500 (-66.46%)
since 12/24/24

Most Recent Stories

More News
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off NEXGEL will also receive a 5% global royalty in perpetuity on...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL Reports Third Quarter 2025 Financial Results

LANGHORNE, Pa., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL to Report Third Quarter 2025 Financial Results on November 11th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”),...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21

LANGHORNE, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL Reports Second Quarter 2025 Financial Results

Second quarter 2025 revenue totaled $2.88 million, an increase of 100.3% as compared to $1.44 million for the same period year-over-year Gross Profit for the quarter was 43.6%, compared to 20.3% for...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors

LANGHORNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle,...

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL and STADA AG Announce Expansion of Partnership for North America

LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc.

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)
NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd

NXGL : 1.5900 (+1.92%)
NXGLW : 0.1960 (-0.51%)

Business Summary

NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa.

See More

Key Turning Points

3rd Resistance Point 1.6467
2nd Resistance Point 1.6233
1st Resistance Point 1.6067
Last Price 1.5900
1st Support Level 1.5667
2nd Support Level 1.5433
3rd Support Level 1.5267

See More

52-Week High 4.9500
Fibonacci 61.8% 3.6130
Fibonacci 50% 3.2000
Fibonacci 38.2% 2.7870
Last Price 1.5900
52-Week Low 1.4500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar